← Leaderboards
Kenneth Dretchen
Mesa Science Associates, Inc.
$1,004,451
Attributed
$1,697,520
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,697,520 · 3
By mechanism
R44$980,358 · 1
R61$405,781 · 1
R43$311,381 · 1
Top collaborators
- Gerry R Boss2 shared
Others in their field
Other Rising Stars on “Cobalamin”
- Qiang Zhang · Michigan State University$878,876
- Romila Nina Mascarenhas · University Of Michigan At Ann Arbor$717,907
- Shirin Ghods · University Of Louisville$586,875
- Victoria L Castro · University Of Texas El Paso$310,298
- Nicholas James York · Pennsylvania State University, The$147,540
Research focus
CobalaminPharmaceutical PreparationsVitamin B 12CobinamideFormulationDosePersonsReactive Oxygen SpeciesAbsorptionAnalogRattusAnimalsExtracellular Matrix ProteinsAntidotesAneurysmDrinking WaterDrug KineticsFamily SuidaeCommercializationCobaltCyanidesAscending AortaAffinityAortic Aneurysm
Grant awards (3)
Development of Cobinamide as a Cyanide Antidote: Completion of pre-IND Studies$980,358
R44 · FY2025 · AI · contact PI
Cobinamide as a disease-modifying treatment for Marfan Syndrome: optimizaation of absorption$405,781
R61 · FY2025 · HL
Development of Cobinamide as a Novel Treatment for Aortic Aneurysms of Marfan Syndrome: Phase I Pharmacokinetic Studies$311,381
R43 · FY2022 · HL · contact PI